How many FDA actions does Argus HQ track for Becton Dickinson & Company?

13 total: 0 warning letters, 13 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Becton Dickinson & Company?

June 10, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Becton Dickinson & Company had product recalls?

Yes, 13 recalls on file. See the full history below for each one.

Is this FDA enforcement data for Becton Dickinson & Company official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Becton Dickinson & Company — FDA Enforcement History

FDA action counts

Total FDA actions	13
Warning letters	0
Recalls	13
Approval records	0
Form 483 inspection citations	0
Most recent action	June 10, 2026

Key takeaway: Argus HQ has recorded 13 FDA events for Becton Dickinson & Company: 0 warning letters, 13 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-05-27 to 2026-06-10. The most severe rating Argus HQ has assigned across this history is "critical". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Enforcement history

On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Jr Catheter, Models: SGPT54, SGPT64P, SGPT755P An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Pacing Catheter, Models: D200F7; An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-05-27, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company — Class II recall: Swan-Ganz Catheter, Models: 131F7/131F7P, 131F7J, 141F7, 151F7, 834F75, 096F6/09… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in., BD¿Quincke Needle 22 G x… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An FDA recall record reflects a firm removing or correcting a product already in distribution because it does not meet FDA requirements. On 2026-06-10, Argus HQ recorded a FDA recall for Becton Dickinson & Company, rated "critical" severity in Argus HQ's classification: Becton Dickinson & Company — Class I recall: BD¿Spinal Tray with BD¿Quincke Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL,… An.

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Becton Dickinson & Company has 13 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

How many FDA actions does Argus HQ track for Becton Dickinson & Company?: 13 total: 0 warning letters, 13 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Becton Dickinson & Company?: June 10, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Becton Dickinson & Company had product recalls?: Yes, 13 recalls on file. See the full history below for each one.
Is this FDA enforcement data for Becton Dickinson & Company official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Becton Dickinson & Company — FDA Enforcement History. Digital Empire LLC. Retrieved from https://argushq.ai/company/becton-dickinson-and-company

MLA

"Becton Dickinson & Company — FDA Enforcement History." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/becton-dickinson-and-company.

Chicago

Argus HQ Research. "Becton Dickinson & Company — FDA Enforcement History." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/becton-dickinson-and-company.

BibTeX

@misc{argushq_argushq_ai_company_becton_dickinson_and_company_2026,
  title = {Becton Dickinson & Company — FDA Enforcement History},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/becton-dickinson-and-company},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗